Connecting to SEC EDGAR… PricingSign in
← All filings

PYXS

Pyxis Oncology, Inc. SEC filings
Pharmaceutical Preparations · Nasdaq · Incorporated in DE
On the radar right now · 0
Nothing in the live feed for PYXS right now.
Filing history
2026-11-06
Insider trade 4
Filing ↗
2026-11-05
Quarterly report 10-Q
Filing ↗
2026-11-05
Current report 8-K
Earnings results
Filing ↗
2026-11-03
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-10-21
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-10-09
PRE 14A PRE 14A
Filing ↗
2026-10-09
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-10-09
Insider trade (amended) 4/A
Filing ↗
2026-10-05
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-10-02
Insider trade 4
Filing ↗
2026-10-02
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-10-01
Current report 8-K
Material agreementOther event
Filing ↗
2026-10-01
Prospectus 424B5
Filing ↗
2026-09-29
Prospectus 424B5
Filing ↗
2026-09-29
Prospectus 424B5
Filing ↗
2026-09-09
Current report 8-K
Reg FD disclosureOther event
Filing ↗
2026-09-08
Insider trade 4
Filing ↗
2026-09-08
Current report 8-K
Exec/director changeReg FD disclosure
Filing ↗
2026-08-28
Prospectus 424B2
Filing ↗
2026-08-27
EFFECT EFFECT
Filing ↗
2026-08-20
Insider trade 4
Filing ↗
2026-08-20
Shelf registration (future share sales) S-3
Filing ↗
2026-08-14
Insider trade 4
Filing ↗
2026-08-13
Quarterly report 10-Q
Filing ↗
2026-08-13
Current report 8-K
Earnings results
Filing ↗
2026-07-10
New insider's holdings 3
Filing ↗
2026-07-10
Passive 5%+ stake SCHEDULE 13G
Filing ↗
2026-07-02
Insider trade 4
Filing ↗
2026-07-02
Current report 8-K
Material agreementShare sale (dilution)Reg FD disclosure
Filing ↗
2026-07-02
Passive 5%+ stake update SCHEDULE 13G/A
Filing ↗
2026-06-30
Planned insider sale 144
Filing ↗
2026-06-15
Current report 8-K
Shareholder vote
Filing ↗
2026-05-14
Quarterly report 10-Q
Filing ↗
2026-05-14
Current report 8-K
Earnings results
Filing ↗
2026-04-30
Annual report to shareholders ARS
Filing ↗
2026-04-30
Proxy material DEFA14A
Filing ↗
2026-04-30
Proxy statement (shareholder vote) DEF 14A
Filing ↗
2026-04-30
Current report (amended) 8-K/A
Exec/director change
Filing ↗
2026-03-25
Insider trade 4
Filing ↗
2026-03-25
Insider trade 4
Filing ↗